Stockscreener 앱 받기
33.33
4.03%
1.29
시장 영업 전:
33.80
0.47
+1.41%
전일 마감가:
$32.04
열려 있는:
$31.77
하루 거래량:
866.91K
Relative Volume:
0.86
시가총액:
$1.54B
수익:
$596.57M
순이익/손실:
$-109.88M
주가수익비율:
-8.6033
EPS:
-3.8741
순현금흐름:
$28.72M
1주 성능:
+11.55%
1개월 성능:
+31.43%
6개월 성능:
+11.14%
1년 성능:
+14.81%
1일 변동 폭
$31.77
$33.54
1주일 범위
$29.06
$33.54
52주 변동 폭
$15.93
$41.73
Azenta Inc Stock (AZTA) Company Profile
명칭
Azenta Inc
전화
(978) 262-2400
주소
200 SUMMIT DRIVE, BURLINGTON
Compare AZTA vs ISRG, BDX, ALC, RMD, MDLN
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
AZTA
Azenta Inc
|
33.33 | 1.27B | 596.57M | -109.88M | 28.72M | -3.8741 |
ISRG
Intuitive Surgical Inc
|
393.38 | 127.84B | 11.03B | 3.16B | 3.22B | 8.7251 |
BDX
Becton Dickinson Co
|
179.63 | 43.79B | 21.37B | 1.41B | 3.07B | 3.9437 |
ALC
Alcon Inc
|
73.63 | 32.81B | 10.63B | 819.00M | 1.59B | 1.6577 |
RMD
Resmed Inc
|
220.05 | 29.46B | 5.54B | 1.52B | 1.74B | 10.37 |
MDLN
Medline Inc
|
33.81 | 33.57B | 29.14B | 1.07B | 1.05B | 1.1956 |
Azenta Inc Stock (AZTA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-01-05 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2025-12-19 | 재확인 | Needham | Buy |
| 2025-10-30 | 업그레이드 | Jefferies | Hold → Buy |
| 2025-08-06 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2025-07-22 | 재개 | Stephens | Equal-Weight |
| 2024-12-18 | 업그레이드 | Stephens | Equal-Weight → Overweight |
| 2024-04-04 | 개시 | Jefferies | Hold |
| 2024-02-01 | 재확인 | B. Riley Securities | Buy |
| 2023-07-19 | 개시 | Raymond James | Mkt Perform |
| 2023-05-10 | 다운그레이드 | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-02-09 | 다운그레이드 | Stephens | Overweight → Equal-Weight |
| 2023-01-03 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2022-03-31 | 재개 | B. Riley Securities | Buy |
| 2022-03-21 | 개시 | Evercore ISI | Outperform |
모두보기
Azenta Inc 주식(AZTA)의 최신 뉴스
AZTA|Azenta Inc|Price:27.520|Chg%:+0.150 - TradingKey
Azenta Inc (AZTA) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Azenta Inc (AZTA) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Azenta Inc (AZTA) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Azenta Inc (AZTA) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Azenta Inc (AZTA) Cash Flow - TradingKey
Azenta Inc (AZTA) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Azenta Inc (AZTA) Income Statement - TradingKey
Azenta, Inc. Revenue Breakdown – NASDAQ:AZTA - TradingView
Brooks Automation Weighs IPO Amid Surge in PE-Backed Listings - Briefs Finance
Azenta, Inc. Revenue Breakdown – LSE:0HQ1 - TradingView
Brooks Automation Explores IPO Opportunities Amid Azenta (AZTA) Transition - GuruFocus
Robotics firm Brooks Automation weighs IPOBloomberg By Investing.com - Investing.com Canada
Azenta Inc (AZTA) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Azenta Inc. (AZTA) Q2 2026 Earnings: EPS Misses Estimates Sharply, Stock Edges HigherTech Earnings Analysis - dars.gov.et
Green Alpha Advisors, LLC's Azenta Inc(AZTA) Holding History - GuruFocus
Azenta to announce fiscal Q3 2026 earnings on Aug 4 - scanx.trade
Azenta Inc. (AZTA) Bounces Back: Could a 2.14% Gain Signal a Potential Turnaround?ADD Alert - dars.gov.et
Azenta to report quarter ended June 30 after market close - Stock Titan
Azenta Announces Fiscal 2026 Third Quarter Conference Call and Webcast - AOL.ca
Azenta (AZTA) Q1 2025 earnings summary - Quartr
Azenta (AZTA) AGM 2026 Summary - Quartr
Azenta (AZTA) M&A announcement Summary - Quartr
BA3 Forecast — Price Target — Prediction for 2027 - TradingView
Azenta (AZTA) Q1 2026 earnings summary - Quartr
Azenta (AZTA) Investor Day 2025 Summary - Quartr
Azenta (AZTA) Q2 2026 earnings summary - Quartr
AZTA Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Why is Azenta (AZTA) Trading So Low Despite Strong Balance Sheet - Kavout | AI
Azenta announces completion of B Medical Systems sale to Thelema S.a r.l; Whitestone Group acquires a 40% Stake in Thelema S.a r.l, a Special Purpose Vehicle (SPV) established for the ownership of B Medical Systems - News-Medical
Azenta Completes Strategic Divestiture to Streamline Portfolio - The Globe and Mail
Azenta completes $63 million B Medical Systems sale - grafa.com
Azenta Sells B Medical Systems to Thelema for $63 Million, Advances Focus on Core Life Sciences Business - Minichart
Azenta completes sale of B Medical Systems for $63 million By Investing.com - Investing.com Nigeria
Press Release: Azenta Completes Sale of B Medical Systems - Moomoo
Azenta Finalizes B Medical Divestiture With $35 Million Vendor Loan and Share Pledge - TradingView
Azenta completes sale of B Medical Systems for $63 million - Investing.com
Azenta Completes Sale of B Medical Systems - Yahoo Finance
Azenta, Inc. (AZTA) Securities Fraud InvestigationLevi & Korsinsky - AOL.com
Azenta Inc. (AZTA) Slides 1.23% as Stock Tests Key Support LevelsLate Stage Breakouts - dars.gov.et
How Azenta’s Dual Russell 2000 Defensive Index Addition Will Impact Azenta (AZTA) Investors - simplywall.st
Azenta, Inc. (AZTA) Investigation: Bronstein, Gewirtz & Grossman - The National Law Review
AZTAAzenta Inc Options - Finviz
AZTA SEC FilingsAzenta Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Azenta (NASDAQ:AZTA) Shift Puts Its Defensive Story In Focus - Kalkine Media
ETFs Investing in Azenta, Inc. Stocks - TradingView
Is There Now An Opportunity In Azenta, Inc. (NASDAQ:AZTA)? - Moomoo
Does Azenta (AZTA) Joining Defensive Russell Indexes Recast Its Role as a Value-Oriented Compounder? - simplywall.st
Azenta, Inc.(NasdaqGS: AZTA) added to Russell 2000 Value-Defensive Index - marketscreener.com
Azenta, Inc.(NasdaqGS: AZTA) added to Russell 2000 Defensive Index - marketscreener.com
Azenta Inc. Q1 2026 Earnings: EPS Misses Expectations, Yet Stock Advances 3.53%Energy Earnings Report - dars.gov.et
Azenta Inc (AZTA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Azenta Inc 주식 (AZTA) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Cornog William L | Director |
May 18 '26 |
Buy |
16.38 |
10,000 |
163,800 |
19,703 |
| Marotta John | President and CEO |
Sep 10 '25 |
Sale |
29.41 |
316 |
9,294 |
105,980 |
| Lin Lawrence Y. | EVP, CFO and Treasurer |
Aug 11 '25 |
Buy |
27.96 |
2,500 |
69,900 |
46,013 |
1.37%
0.55%
자본화:
|
볼륨(24시간):